Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics data
Zoe Kordou(University of Patras), Maria Koromina(University of Patras), Μαρία Σκώκου(University of Patras), George P. Patrinos(University of Patras), Evangelia Eirini Tsermpini(University of Patras), Wasun Chantratita(Mahidol University), Taisei Mushiroda(RIKEN Center for Integrative Medical Sciences), Koya Fukunaga(RIKEN Center for Integrative Medical Sciences)
Cited by 10
Related Papers
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
|The Lancet|2023|508
Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity
|Human Genomics|2020|213
Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer’s disease measured by pulsed arterial spin labeling MRI
|European Archives of Psychiatry and Clinical Neuroscience|2011|124